Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Endocrine 1CNS 1

Conditions

Wilms Tumor 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Rhabdomyosarcoma, Alveolar 1Rhabdomyosarcoma 1Retinoblastoma 1Neuroblastoma 1Medulloblastoma 1Glioblastoma 1Carcinoid Tumor 1

Interventions

Temozolomide 15Filgrastim 13Cyclophosphamide 9Carboplatin 9Granulocyte Colony-Stimulating Factor 7Etoposide 7Thiotepa 5Peripheral Blood Stem Cell Transplantation 5Melphalan 5Vorinostat 4Busulfan 4sonidegib 3ribociclib 3Vincristine 3Topotecan 3O(6)-benzylguanine 3Magnetic Resonance Spectroscopy 3Irinotecan 3Automobiles 3veliparib 2sargramostim 2pembrolizumab 2fludarabine 2etoposide phosphate 2Valproic Acid 2Thalidomide 2Surgical Procedures, Operative 2Stem Cell Transplantation 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Medulloblastoma × Biological Factors × Clear all
NCT00314925 2010-02-25

Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features

Neotropix

Phase 1 Unknown
60 enrolled
CNSEndocrineGenitourinaryOther solid neoplasmSarcoma

Carcinoid Tumor, Glioblastoma, Medulloblastoma, Wilms Tumor, Neuroblastoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Rhabdomyosarcoma, Alveolar

Data powered by HemOnc (CC BY 4.0) Colophon âš¡